Witzig TE - Search Results

1

Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma.

Wang Y, Link BK, Witzig TE, Maurer MJ, Allmer C, King RL, Feldman AL, Habermann TM, Ansell SM, Slager SL, Cerhan JR, Nowakowski GS. Wang Y, et al. Among authors: witzig te. Blood. 2019 Oct 17;134(16):1289-1297. doi: 10.1182/blood.2019000858. Blood. 2019. PMID: 31350266 Free PMC article.

2

Rapid immunotyping of B-cell non-Hodgkin's lymphomas by flow cytometry. A comparison with the standard frozen-section method.

Witzig TE, Banks PM, Stenson MJ, Griepp PR, Katzmann JA, Habermann TM, Colgan JP, Gonchoroff NJ. Witzig TE, et al. Am J Clin Pathol. 1990 Sep;94(3):280-6. doi: 10.1093/ajcp/94.3.280. Am J Clin Pathol. 1990. PMID: 2204263

3

Rapid S-phase determination of non-Hodgkin's lymphomas with the use of an immunofluorescence bromodeoxyuridine labeling index procedure.

Witzig TE, Gonchoroff NJ, Greipp PR, Katzmann JA, Stenson MJ, Habermann TM, Colgan JP, Therneau TM, Banks PM. Witzig TE, et al. Am J Clin Pathol. 1989 Mar;91(3):298-301. doi: 10.1093/ajcp/91.3.298. Am J Clin Pathol. 1989. PMID: 2646907

4

Immunofluorescence labeling indices in myeloma and related monoclonal gammopathies.

Greipp PR, Witzig TE, Gonchoroff NJ, Habermann TM, Katzmann JA, O'Fallon WM, Kyle RA. Greipp PR, et al. Among authors: witzig te. Mayo Clin Proc. 1987 Nov;62(11):969-77. doi: 10.1016/s0025-6196(12)65066-6. Mayo Clin Proc. 1987. PMID: 3118117

5

True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases.

Hoyer JD, Ross CW, Li CY, Witzig TE, Gascoyne RD, Dewald GW, Hanson CA. Hoyer JD, et al. Among authors: witzig te. Blood. 1995 Aug 1;86(3):1163-9. Blood. 1995. PMID: 7620169 Free article. Review.

6

Primary renal non-Hodgkin's lymphoma. An unusual extranodal site.

Okuno SH, Hoyer JD, Ristow K, Witzig TE. Okuno SH, et al. Among authors: witzig te. Cancer. 1995 May 1;75(9):2258-61. doi: 10.1002/1097-0142(19950501)75:9<2258::aid-cncr2820750911>3.0.co;2-s. Cancer. 1995. PMID: 7712433 Review.

7

Chronic natural killer cell lymphocytosis: a descriptive clinical study.

Tefferi A, Li CY, Witzig TE, Dhodapkar MV, Okuno SH, Phyliky RL. Tefferi A, et al. Among authors: witzig te. Blood. 1994 Oct 15;84(8):2721-5. Blood. 1994. PMID: 7919384 Free article.

8

Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma.

Greipp PR, Lust JA, O'Fallon WM, Katzmann JA, Witzig TE, Kyle RA. Greipp PR, et al. Among authors: witzig te. Blood. 1993 Jun 15;81(12):3382-7. Blood. 1993. PMID: 8507875 Free article.

9

S-phase fraction by the labeling index as a predictive factor for progression and survival in low grade non-Hodgkin's lymphoma.

Witzig TE, Habermann TM, Kurtin PJ, Schroeder G, Stenson MJ, Greipp PR. Witzig TE, et al. Cancer. 1995 Sep 15;76(6):1059-64. doi: 10.1002/1097-0142(19950915)76:6<1059::aid-cncr2820760621>3.0.co;2-e. Cancer. 1995. PMID: 8625208

10

Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma.

Witzig TE, Gertz MA, Lust JA, Kyle RA, O'Fallon WM, Greipp PR. Witzig TE, et al. Blood. 1996 Sep 1;88(5):1780-7. Blood. 1996. PMID: 8781435 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

643 results

Search Page

Filters